[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338797-105":59,"doc-detail-338797-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","crabp2-affects-chemotherapy-resistance-of-ovarian-cancer-by-regulating-the-expression-of-hif1","CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α","","Ovarian cancer remains highly lethal, largely driven by primary and acquired chemotherapy resistance, yet the underlying mechanisms are incompletely understood. This study reports that CRABP2 expression is elevated in drug-resistant ovarian cancer tissues and cell lines and correlates with clinical stage and patient prognosis. Mechanistic experiments show that CRABP2 is linked to higher metabolic activity, that all-trans retinoic acid amplifies this activity, and that CRABP2 upregulates HIF1α while promoting its nuclear localization. HIF1α knockdown blocks CRABP2-mediated drug resistance, identifying a potential molecular target for therapeutic intervention.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/crabp2-affects-chemotherapy-resistance-of-ovarian-cancer-by-regulating-the-expression-of-hif1/338797/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/crabp2-affects-chemotherapy-resistance-of-ovarian-cancer-by-regulating-the-expression-of-hif1/338797.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the key relationship between CRABP2 and chemotherapy resistance in ovarian cancer?","Question",{"text":112,"@type":113},"CRABP2 expression increases in drug-resistant ovarian cancer, and the study concludes that CRABP2 affects chemotherapy resistance by regulating HIF1α expression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CRABP2 influence HIF1α in drug-resistant ovarian cancer cells?",{"text":117,"@type":113},"CRABP2 upregulates HIF1α expression and enhances HIF1α localization in the nucleus in drug-resistant ovarian cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to drug resistance when HIF1α is knocked down?",{"text":121,"@type":113},"Knocking down HIF1α blocks CRABP2’s resistance effect to chemotherapy drugs in ovarian cancer cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338797,1790917525,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nCRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α  \nXin Fu 1,2,3,4,8 ✉, Qian Zhang 1,2,3,5,8, Zhaosong Wang 1,2,3,6, Yue Xu1,2,3,7 and Qiuping Dong 1,2,3,7  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Ovarian cancer is the most lethal malignancy among gynecologic cancers, and primary and secondary chemotherapy resistance isone of the important reasons for poor prognosis of ovarian cancer patients. However, the speciﬁcs of resistance to chemotherapy in ovarian cancer remain unclear. Herein, we ﬁnd that the expression level of cellular retinoic acid binding protein 2 (CRABP2) is upregulated in drug-resistant ovarian cancer tissues and cell lines, and the expression levels of CRABP2 in epithelial ovarian cancer tissues are closely related to tumor clinical stage and patients’ prognosis, suggesting that CRABP2 plays an important role in the progression of ovarian cancer and the corresponding ability of tumor to chemotherapy. With the in-depth study, we demonstrates that CRABP2 is related to the high metabolic activity in drug-resistant cells, and all-trans retinoic acid exacerbates this activity. Further molecular mechanism exploration experiments show that CRABP2 not only up-regulates the expression level of HIF1α, but also increases the localization of HIF1α in the nucleus. In drug-resistant ovarian cancer cells, knocking down HIF1α can block the resistance of CRABP2 to chemotherapy drugs in ovarian cancer cells. Taken together, our ﬁndings suggest for the ﬁrst time that CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α . This study provides a possible |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| molecular mechanism for drug resistance and a possible molecular target for clinical treatment of ovarian cancer. |  |  |\n|  | Cell Death and Disease (2024)15:21; [https://doi.org/10.1038/s41419-023-06398-4](https://doi.org/10.1038/s41419-023-06398-4) |  |\n|  |  |  |\n\nINTRODUCTION  \nOvarian cancer is the most lethal malignancy among the three major gynecologic cancers, with the third-highest incidence rate in gynecologic tumors [1] . However, it has the highest mortality rate, posing a serious threat to the life and health of female patients [2] . Due to its location in the abdominal cavity, early symptoms of ovarian cancer are insidious, and approximately 75% of patients are diagnosed at an advanced stage with widespread metastasis, where simple surgery cannot eliminate the tumor [3] . Therefore, surgery combined with platinum-based chemotherapy is a commonly used clinical treatment for ovarian cancer. Although most ovarian cancer patients are relatively sensitive to platinum-based chemotherapy in the early stages, more than 60% of patients experience recurrence [4] . Furthermore, many patients develop secondary drug resistance after chemotherapy, which directly leads to the inability of chemotherapy drugs to effectively inhibit ovarian cancer cells, resulting in disease progression and seriously affecting the survival and quality of life of ovarian cancer patients [5–9] . Therefore, ovarian cancer drug resistance has become a difﬁcult problem in clinical treatment, and the study of its mechanisms is particularly important, as these studies will provide new ideas for reversing ovarian cancer drug resistance.  \nCellular retinoic acid binding protein 2 (CRABP2) belongs to theretinoic acid binding protein family and the lipid calcium-binding  \nprotein/cytosolic fatty acid binding protein family, and is mainly involved in retinoic acid (RA) signal transduction [10] . RA is a critical regulatory factor in gene expression during embryonic development, playing an important role in cell growth and differentiation [11] . CRABP2 is a nuclear shuttle protein that can transport RA from cytoplasm to n","cbCaiuqXC5C8QNgR","https://ap.wps.com/l/cbCaiuqXC5C8QNgR","pdf",6829520,13,"English","# Introduction\n## Chemotherapy resistance in ovarian cancer\n## Role of CRABP2 and retinoic acid signaling\n# Main findings\n## CRABP2 upregulation in resistant models\n## CRABP2 regulates HIF1α expression and nuclear localization\n## HIF1α knockdown reverses resistance","[{\"question\":\"What is the key relationship between CRABP2 and chemotherapy resistance in ovarian cancer?\",\"answer\":\"CRABP2 expression increases in drug-resistant ovarian cancer, and the study concludes that CRABP2 affects chemotherapy resistance by regulating HIF1α expression.\"},{\"question\":\"How does CRABP2 influence HIF1α in drug-resistant ovarian cancer cells?\",\"answer\":\"CRABP2 upregulates HIF1α expression and enhances HIF1α localization in the nucleus in drug-resistant ovarian cancer cells.\"},{\"question\":\"What happens to drug resistance when HIF1α is knocked down?\",\"answer\":\"Knocking down HIF1α blocks CRABP2’s resistance effect to chemotherapy drugs in ovarian cancer cells.\"}]","CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α | PDF",1790025759,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b23fc836c02c00c124ad1b2526fdd96b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f42fb1761677a7848e251c82edf73daa.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ad175cb39a416ff89a65df45ac679bb.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72f0f7d4c5cb3d5744911a81b912e246.webp",980,1301]